Cargando…

An immune-related gene prognostic risk index for pancreatic adenocarcinoma

OBJECTIVE: Our goal is to construct an immune-related gene prognostic risk index (IRGPRI) for pancreatic adenocarcinoma (PAAD), and to clarify the immune and molecular features in IRGPRI-defined PAAD subgroups and the benefit of immune checkpoint inhibitors (ICIs) therapy. METHOD: Through differenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yang, Qi, Ruoshan, Li, Lanying, Wang, Xu, Li, Sijin, Zhao, Xuan, Hou, Rui, Ma, Wen, Liu, Dan, Zheng, Junnian, Shi, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360334/ https://www.ncbi.nlm.nih.gov/pubmed/35958614 http://dx.doi.org/10.3389/fimmu.2022.945878

Ejemplares similares

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses
por: Meng, Bi, et al.
Publicado: (2023)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2022)

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma
por: Sun, Ziquan, et al.
Publicado: (2022)

Single-cell sequencing reveals heterogeneity between pancreatic adenosquamous carcinoma and pancreatic ductal adenocarcinoma with prognostic value
por: Zhang, Deyu, et al.
Publicado: (2022)

Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma
por: Yuan, Hao, et al.
Publicado: (2021)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease
por: Ren, Bin, et al.
Publicado: (2021)

International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
por: Mu, Shidai, et al.
Publicado: (2021)

Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
por: Zou, Xuan, et al.
Publicado: (2023)

The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer
por: Li, Jinze, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Long noncoding RNA NONHSAT160169.1 promotes resistance via hsa-let-7c-3p/SOX2 axis in gastric cancer
por: Zhao, Xuan, et al.
Publicado: (2023)

Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes
por: de Koning, Willem, et al.
Publicado: (2021)

Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma
por: Huang, Qian, et al.
Publicado: (2023)

Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification
por: Chen, Yi, et al.
Publicado: (2022)

An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer
por: Li, Chao, et al.
Publicado: (2023)

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma
por: Zhang, Xiaonan, et al.
Publicado: (2022)

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
por: Kabacaoglu, Derya, et al.
Publicado: (2018)

Identification of prognostic immune-related lncRNAs in pancreatic cancer
por: Ma, Yan, et al.
Publicado: (2022)

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
por: Park, Hyung Soon, et al.
Publicado: (2016)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2023)

The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment
por: Chen, Xintian, et al.
Publicado: (2022)

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
por: Rong, Min-hua, et al.
Publicado: (2020)

5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
por: Ebelt, Nancy D., et al.
Publicado: (2020)

The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis
por: Yang, Bing, et al.
Publicado: (2021)

Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2023)

From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors
por: Wei, Miaoyan, et al.
Publicado: (2021)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy
por: Zhang, Shiyu, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
por: Yao, Yan, et al.
Publicado: (2022)

B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2022)

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
por: Mi, Haoyang, et al.
Publicado: (2022)

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
por: Xiao, Mingjia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oms7e016q6p728devi9dr5b5l6